Community pharmacist–led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer-Reference-Cited by-同舟云学术

Community pharmacist–led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer

Published:2017-09-22 Issue:6 Volume:150 Page:362-365
ISSN:1715-1635
Container-title:Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
language:en
Short-container-title:Can Pharm J

Author:

Yokoyama Satoshi¹²³,Yajima Satoko¹²³,Sakai Chihiro¹²³,Yamashita Shuji¹²³,Noguchi Yoshihiro¹²³,Ino Yoko¹²³,Iguchi Kazuhiro¹²³,Teramachi Hitomi¹²³

Affiliation:

1. Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan

2. Laboratory of Pharmacy Practice and Social Science (Yamashita), Gifu Pharmaceutical University, Gifu, Japan

3. Laboratory of Clinical Pharmacy (Noguchi, Teramachi), Gifu Pharmaceutical University, Gifu, Japan

Publisher

SAGE Publications

Subject

Pharmaceutical Science,Pharmacy

Link

http://journals.sagepub.com/doi/pdf/10.1177/1715163517732088

Reference14 articles.

1. Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

2. Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2

3. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

4. Follow-up telephone calls to patients discharged after undergoing orthopaedic surgery: double-blind, randomised controlled trial of efficacy

5. Preventive effect of gargling with sodium azulene sulfonate on everolimus-induced stomatitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Situation and Challenges of Community-pharmacist-led Follow-up of Patients: A Cross-sectional Questionnaire Survey at Community Pharmacies;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2023-04-10

2. Pharmacists’ knowledge, attitudes, beliefs, and barriers toward breast cancer health promotion: a cross-sectional study in the Palestinian territories;BMC Health Services Research;2021-05-06

3. Telepharmacy in oncology care: A scoping review;Journal of Telemedicine and Telecare;2020-12-30

4. Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2018-10-11

5. Everolimus;Reactions Weekly;2017-12